| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | TESARO INC | 514,000 | 43,202,000 | 9.60% | ||
| 2 | Lion Biotechnologies | 4,338,557 | 35,142,000 | 7.81% | ||
| 3 | CELATOR PHARMACEUTICALS INC | 1,124,666 | 33,942,000 | 7.54% | ||
| 4 | BIOMARIN | 432,972 | 33,685,000 | 7.49% | ||
| 5 | BRISTOL MYERS SQUIBB CO | 445,339 | 32,755,000 | 7.28% | ||
| 6 | SAREPTA THERAPEUTICS INC | 1,412,190 | 26,930,000 | 5.98% | ||
| 7 | NEUROCRINE BIOSCIE COM USD0.001 | 509,330 | 23,149,000 | 5.14% | ||
| 8 | DERMIRA INC | 721,663 | 21,109,000 | 4.69% | ||
| 9 | AMICUS THERAPEUTICS INC | 3,698,665 | 20,195,000 | 4.49% | ||
| 10 | IMMUNOMEDICS INC | 8,556,957 | 19,852,000 | 4.41% | ||
| 11 | MEDIVATION INC | 279,700 | 16,866,000 | 3.75% | ||
| 12 | GLOBAL BLOOD THERAPEUTICS IN COM | 963,646 | 15,987,000 | 3.55% | ||
| 13 | AGENUS INC | 3,099,838 | 12,554,000 | 2.79% | ||
| 14 | RELYPSA INC | 613,300 | 11,346,000 | 2.52% | ||
| 15 | ACADIA PHARMACEUTICALS INC COM | 329,500 | 10,696,000 | 2.38% | ||
| 16 | SORRENTO THERAPEUTICS INC COM NEW | 1,655,274 | 9,270,000 | 2.06% | ||
| 17 | TELIGENT INC NEW | 1,290,000 | 9,211,000 | 2.05% | ||
| 18 | GILEAD SCIENCES INC | 108,500 | 9,051,000 | 2.01% | ||
| 19 | NEURODERM LTD | 557,003 | 9,051,000 | 2.01% | ||
| 20 | VANDA PHARMACEUTICALS INC COM | 709,579 | 7,940,000 | 1.76% | ||
| 21 | MIRATI THERAPEUTICS INC COM | 1,214,833 | 6,633,000 | 1.47% | ||
| 22 | CASCADIAN THERAPEUTICS INC | 5,744,723 | 5,418,000 | 1.20% | ||
| 23 | CYTOKINETICS INC | 503,900 | 4,782,000 | 1.06% | ||
| 24 | AKEBIA THERAPEUTICS INC | 621,873 | 4,652,000 | 1.03% | ||
| 25 | VERACYTE INC | 918,556 | 4,620,000 | 1.03% | ||
| 26 | FORTRESS BIOTECH INC | 1,326,636 | 3,569,000 | 0.79% | ||
| 27 | SAREPTA THERAPEUTICS INC | 624,600 | 2,603,000 | 0.58% | Call | |
| 28 | INNOCOLL HLDGS PLC | 468,148 | 2,579,000 | 0.57% | ||
| 29 | TRILLIUM THERAPEUTICS INC | 228,697 | 2,054,000 | 0.46% | ||
| 30 | SAREPTA THERAPEUTICS INC | 1,332,000 | 2,006,000 | 0.45% | Put | |
| 31 | ONCOBIOLOGICS INC | 466,667 | 1,587,000 | 0.35% | ||
| 32 | PERNIX THERAPEUTICS HOLDINGS INC | 7,000,000 | 1,487,000 | 0.33% | PRN | |
| 33 | ASSEMBLY BIOSCIENCES INC | 260,982 | 1,448,000 | 0.32% | ||
| 34 | CELLECTIS S A | 42,671 | 1,135,000 | 0.25% | ||
| 35 | LA JOLLA PHARMACEUTICAL CO | 70,000 | 1,120,000 | 0.25% | ||
| 36 | CORVUS PHARMACEUTICALS INC COM | 74,800 | 1,067,000 | 0.24% | ||
| 37 | VERICEL CORP | 255,000 | 574,000 | 0.13% | ||
| 38 | Nantkwest Inc | 72,412 | 450,000 | 0.10% | ||
| 39 | ONCOBIOLOGICS INC - WARRANT A | 233,333 | 107,000 | 0.02% | ||
| 40 | ONCOBIOLOGICS INC - WARRANT B | 233,333 | 105,000 | 0.02% | ||
| 41 | IMMUNOMEDICS INC | 453,900 | 64,000 | 0.01% | Call | |
| 42 | ISHARES TR | 50,000 | 19,000 | 0.00% | Put |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-16-119420, filed 2016.08.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
